Post-earnings recap
Reported
Thu, Aug 7, 2025
EPS actual
$0.00
EPS est.
$-0.05
EPS surprise
+100.00%
1-day move
-3.23%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported an EPS of $0.00, meeting expectations, but did not provide revenue figures. The stock reacted negatively, declining by 3.23%. The lack of guidance and further details from the earnings call may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.00 | N/A | +100.00% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.